The Molecular and Serological Investigation of Feline Immunodeficiency Virus and Feline Leukemia Virus in Stray Cats of Western Turkey

Author(s):  
Dilek Muz ◽  
Hüseyin Can ◽  
Muhammet Karakavuk ◽  
Mert Döşkaya ◽  
Hüseyin Gökhan Özdemir ◽  
...  
2010 ◽  
Vol 12 (6) ◽  
pp. 435-440 ◽  
Author(s):  
Patrick J. Kelly ◽  
Lenita Moura ◽  
Tanya Miller ◽  
Jaime Thurk ◽  
Nicole Perreault ◽  
...  

2014 ◽  
Vol 64 (3) ◽  
pp. 378-385 ◽  
Author(s):  
Potkonjak Aleksandar ◽  
Vračar Vuk ◽  
Stančić Ivan ◽  
Spasojević Kosić Ljubica ◽  
Bacić Dragan ◽  
...  

Abstract The aim of this study was to determine the prevalence of coinfection with pathogens Bartonella henselae, feline immunodeficiency virus, and feline leukemia virus in stray cats from the area of Novi Sad and Belgrade, Serbia. Each of 60 individual cats was clinically examined and the blood sampled. Therewithal an epidemiological survey was made. Blood sera were separated by centrifugation and serologically tested in order to determine the presence of Bartonella henselae specific antibodies (by direct immunofluorescence assay), feline immunodeficiency virus specific antibodies (by rapid test SNAP Combo) and feline leukemia virus antigens (by rapid test SNAP Combo). Of the 60 cat sera, serologically examined using IFA test, 33 (55%) were positive for the presence of IgG specifi c to B. henselae antigens. A total of 13 (27%) of the 60 tested cat sera were positive for the presence of specific antibodies to FIV antigens. None of the 60 tested cat sera were positive for the presence of FeLV antigen. Of the 33 cat sera which contained IgG antibodies to B. henselae, 6 cat sera also gave a positive reaction to the presence of specific IgG antibodies to FIV; this was a coinfection seroprevalence of 10% in the total population of studied cats. The results obtained in this study indicate the presence of B. henselae and FIV coinfection in cats from Serbia, without FeLV positive cats. An increase in the manifestations of clinical symptoms in cats in which the serological tests determined coinfection with B. henselae and FIV is evident compared to those seropositive only to B. henselae.


2021 ◽  
Vol 8 ◽  
pp. 24-38
Author(s):  
Jelena Raukar

This study aimed to determine prevalences for anti-FCoV antibody, FeLV antigen, FeLV proviral DNA, and anti-FIV antibody among client-owned cats from the cities of Zagreb and Varaždin in Croatia. Subjects included 106 client-owned cats tested at the Faculty of Veterinary Medicine, Vienna, Austria. Blood samples were tested with IFA for anti-FCoV antibody and IFA FCoV antibody titeres, with ELISA for FeLV p27 antigen, with PCR for FeLV proviral DNA, and with RIM for anti-FIV antibody. Prevalence of FCoV and FeLV was 41.51% and 6.60%, respectively. A coinfection with FeLV/FCoV and FIV/FCoV prevalence was 7.55% and 5.66%. No cats were coinfected with FIV and FeLV. All three viruses were detected, confirming their presence in Croatia. The seroepidemiological findings demonstrate that both feline retroviruses and feline coronavirus are important feline pathogens in Croatia.


2003 ◽  
Vol 39 (6) ◽  
pp. 533-537 ◽  
Author(s):  
Julie K. Levy ◽  
Patti S. Snyder ◽  
Larissa M. Taveres ◽  
Jennifer L. Hooks ◽  
Mike J. Pegelow ◽  
...  

Necropsies were performed on 630 adult cats in northern Florida to determine the prevalence and risk factors for heartworm infection in cats of this region. Heartworms were identified in 4.9% of cats, and serological evidence of heartworm exposure was present in 17% of cats. Not all cats from which heartworms were recovered were seropositive for heartworm antigen or antibody. There was no association between heartworm infection and co-infection with feline leukemia virus (FeLV) or feline immunodeficiency virus (FIV). Male cats were at higher risk of infection with heartworm, FeLV, or FIV than were females. Because even a single heartworm can cause clinical disease or death in cats, the authors conclude that cats in this region should receive heartworm prophylaxis to prevent heartworm infection.


1993 ◽  
Vol 10 (1) ◽  
pp. 9-13 ◽  
Author(s):  
Robert B. Wiggs ◽  
Heidi B. Lobprise ◽  
James L. Matthews ◽  
Kripal S. Gulliya

Photoactive compounds and drugs are used therapeutically as antibacterial, antiviral and antitumor agents. This report examines the use of a photoactive compound, preactivated merocyanine 540 (pMC540), in the treatment of stomatitis in two cats that are both feline immunodeficiency virus (FIV) positive. One of the cats was also feline leukemia virus (FeLV) positive. Dramatic short term improvement is reported with the dosage regimen and complications.


Sign in / Sign up

Export Citation Format

Share Document